After attending the course, participants will understand the molecular targeting approach to the treatment of cancer; become familiar with new therapeutic radiopharmaceuticals and their clinical results to date; and learn about current and future directions of research.
Nuclear Oncology: From Genotype to Phenotype to Targeted Therapy
Mar 13th, 2008Mar 14th, 2008
Baltimore, MD
US
Latest in Home
AI system cuts DEXA turnaround time, improves reports
August 14, 2026
Prone positioning may benefit women undergoing PBI
August 14, 2026
Lantheus wins FDA approval for tau PET imaging agent
August 14, 2026















